| |
| |
|
| Insider
Information: |
Reed Elizabeth E |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
77,308 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$483,552 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
77,308 |
|
|
| Total
Value |
$483,552 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 12.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Anadys Pharmaceuticals Inc |
ANDS |
Senior Director, Legal... |
2006-04-10 |
1,038 |
2006-01-09 |
0 |
Premium* |
|
|
Travere Therapeutics, Inc |
TVTX |
|
2024-02-01 |
76,270 |
2017-01-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & CORPORATE SECRETARY |
• – – |
2024-02-01 |
4 |
AS |
$8.53 |
$41,495 |
D/D |
(4,764) |
76,270 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & CORPORATE SECRETARY |
• – – |
2024-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
81,034 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & CORPORATE SECRETARY |
• – – |
2024-01-23 |
4 |
AS |
$8.96 |
$18,476 |
D/D |
(2,062) |
56,034 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2023-09-05 |
4 |
AS |
$14.71 |
$26,699 |
D/D |
(1,815) |
58,096 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2023-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,300 |
59,911 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2023-05-10 |
4 |
AS |
$16.59 |
$13,687 |
D/D |
(825) |
56,611 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2023-02-01 |
4 |
AS |
$22.25 |
$57,628 |
D/D |
(2,590) |
57,436 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
20,250 |
60,026 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2023-01-24 |
4 |
AS |
$21.50 |
$44,333 |
D/D |
(2,062) |
39,776 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2022-05-12 |
4 |
AS |
$21.51 |
$22,584 |
D/D |
(1,050) |
41,838 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2022-05-10 |
4 |
AS |
$21.51 |
$19,359 |
D/D |
(900) |
42,888 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2022-01-31 |
4 |
AS |
$27.40 |
$36,990 |
D/D |
(1,350) |
43,788 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2022-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
9,840 |
45,138 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2022-01-24 |
4 |
AS |
$24.98 |
$56,205 |
D/D |
(2,250) |
35,298 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2022-01-11 |
4 |
AS |
$27.40 |
$137,000 |
D/D |
(5,000) |
37,548 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2022-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
42,548 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2021-08-17 |
4 |
S |
$17.12 |
$24,086 |
D/D |
(1,407) |
37,548 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2021-08-13 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
38,955 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2021-05-12 |
4 |
AS |
$19.46 |
$31,623 |
D/D |
(1,625) |
34,455 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2021-05-11 |
4 |
AS |
$19.14 |
$31,103 |
D/D |
(1,625) |
36,080 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2021-02-08 |
4 |
AS |
$31.58 |
$71,055 |
D/D |
(2,250) |
37,705 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2021-02-05 |
4 |
AS |
$31.41 |
$70,673 |
D/D |
(2,250) |
39,955 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2021-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
42,205 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2021-02-03 |
4 |
AS |
$28.91 |
$91,789 |
D/D |
(3,175) |
37,705 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2021-02-02 |
4 |
AS |
$30.75 |
$97,631 |
D/D |
(3,175) |
40,880 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
